To determine the structural basis underlying the therapeutic effects of GSK3β inhibition on adolescent METH exposure-induced behavioral and cognitive deficits in adulthood, we examined the synaptic ultrastructure in the DHP CA1 subregion using transmission electron microscopy (Figure 8 and Supplementary Figure S6). The gene discussed is GSK3B; the disease is Cognitive impairment.